We are live on ! Find out more

3,015 hedge funds and large institutions have $172B invested in Merck in 2022 Q2 according to their latest regulatory filings, with 183 funds opening new positions, 1,352 increasing their positions, 1,132 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

126% more first-time investments, than exits

New positions opened: 183 | Existing positions closed: 81

120% more funds holding in top 10

Funds holding in top 10: 108238 (+130)

26% more call options, than puts

Call options by funds: $2.46B | Put options by funds: $1.96B

19% more repeat investments, than reductions

Existing positions increased: 1,352 | Existing positions reduced: 1,132

13% more capital invested

Capital invested by funds: $152B → $172B (+$19.4B)

2% more funds holding

Funds holding: 2,9523,015 (+63)

1.04% more ownership

Funds ownership: 73.26%74.29% (+1%)

Holders
3,015
Holders Change
+63
Holders Change %
+2.13%
% of All Funds
50.6%
Holding in Top 10
238
Holding in Top 10 Change
+130
Holding in Top 10 Change %
+120.37%
% of All Funds
3.99%
New
183
Increased
1,352
Reduced
1,132
Closed
81
Calls
$2.46B
Puts
$1.96B
Net Calls
+$508M
Net Calls Change
-$228M

MRK Hedge Fund Activity: Q2 2022 in Review

3,015 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2022, worth a combined $172B — up 13% from $152B a quarter earlier.

Buyers outnumbered sellers: 183 funds opened new MRK positions and 81 closed out — a net gain of 102 holders — while 1,352 added to existing stakes and 1,132 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $1.11B. The largest seller was Franklin Resources, cutting an estimated $596M.

  • 3,015 institutional investors held Merck (MRK) as of Q2 2022, up from 2,952 in Q1 2022.
  • Funds reported $172B of Merck stock for Q2 2022, up 13% quarter-over-quarter.
  • 183 funds opened new Merck positions in Q2 2022 and 81 closed out, a net change of +102 holders.
  • The largest Merck buyer in Q2 2022 was Morgan Stanley, an estimated $1.11B added.
  • The largest Merck seller in Q2 2022 was Franklin Resources, an estimated $596M sold.

Based on aggregated 13F filings for Q2 2022.